Biomedican
PrivateLast Round
Crowdfunding
Oct 1, 2021
Total Funding Raised
$3M
Company Overview
Biomedican is a biotechnology company that designs patented low-cost methods of growing high-value compounds, such as rare cannabinoids and astaxanthin, at scale using proprietary yeast fermentation.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clean Manufacturing
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biomedican Comparables
Compare Biomedican with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hyasynth Biologicals Inc. | 93% | |
| Creo | 88% | |
| Cellibre | 87% |
Biomedican Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Oct 1, 2021 | ||||
| Early Funding | Oct 11, 2019 | ||||
| Early Funding | Jan 29, 2018 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 2, 2026
Monthly visitors increased 50% MoM.
- Jan 5, 2026
Monthly visitors grew 76% MoM.
Biomedican Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Biomedican's valuation, stock price, and market status.
Is Biomedican a public or private company?
Biomedican is a private company.
What is the current stock price of Biomedican?
Biomedican is a private company with no public stock price. No recent secondary market data is available.
How much is Biomedican worth (valuation)?
Valuation information for Biomedican is not publicly available.
Can I buy Biomedican stock?
Biomedican shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Biomedican's last funding round?
Biomedican's most recent funding round was Crowdfunding on October 1, 2021.
Who are the main investors in Biomedican?
Investor information for Biomedican is not publicly disclosed.
Will Biomedican IPO soon?
No public IPO plans have been announced for Biomedican.
How can I track Biomedican secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Biomedican's secondary market activity and sign up for updates.